Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility
ChemMedChem · 26.11.2026 · 21 (22)
DOI: 10.1002/cmdc.70570 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 13.11.2026. Verfasst von Joshua Taujanskas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Antiviral Agents, Thiazoles. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Liverpool.
Abstract (Originalsprache)
Recent studies on thiazolide antivirals have identified compounds RM5038 and RM5021 as potent inhibitors of hepatitis B virus (HBV), hepatitis C virus (HCV), and influenza A, although their development has been limited by poor aqueous solubility and rapid metabolic clearance. In this work, a series of novel halogen‐substituted and 4′‐alkylsulfone thiazolide analogs were synthesized using updated convergent synthetic approaches and flexible protecting group strategies. DMPK evaluation demonstrated that 3‐X halogen substitution significantly improved aqueous solubility in parallel to enhancing metabolic stability. Within the chlorothiazolide series, compounds 10g and 10l displayed much improved metabolic stability profiles, excellent aqueous solubility representing a 10‐fold improvement over the parent drug, together with low single‐digit micromolar antiviral (influenza A) activity and acceptable in vitro safety indices. Evaluation of the 4′‐alkylsulfone thiazolides also revealed improved in vitro DMPK profiles while retaining micromolar antiviral potency. SAR analysis indicated that short alkyl sulfone substituents containing two to three carbons are optimal for antiviral activity, while branched alkyl groups may provide additional metabolic advantages. In summary, compounds 10g, 10l, and 15d represent promising early leads for progression to in vivo profiling and additional preclinical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Liverpool, Liverpool, UK.
- Department of Biology, University of Rome Tor Vergata, Rome, Italy.
- Institute of Translational Pharmacology, CNR, Rome, Italy.
ORCID-Profile: Andrew V Stachulski, Simone La Frazia, Paul M O'Neill
Förderung
- University of Liverpool
Zitieren
APA
Taujanskas, J., Pate, S., Stachulski, A. V., Piacentini, S., La Frazia, S., Santoro, M. G., & O'Neill, P. M. (2026). Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70570
Vancouver
Taujanskas J, Pate S, Stachulski AV, Piacentini S, La Frazia S, Santoro MG, et al. Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70570
BibTeX
@article{Taujanskas2026,
author = {Taujanskas, Joshua and Pate, Sophie and Stachulski, Andrew V and Piacentini, Sara and La Frazia, Simone and Santoro, M Gabriella and O'Neill, Paul M},
title = {Defining the Structure–Activity Relationships of Thiazolide Antivirals: Balancing Potency, Metabolic Stability, and Aqueous Solubility},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {22},
doi = {10.1002/cmdc.70570}
}
EUVIMED